Kelli Bridgman
Psychiatric/Mental Health · New Smyrna Beach, FLNPI 1588841977
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (44.8%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 22 manufacturers reported payments, led by Axsome Therapeutics, Inc. at 57.2% of the total. 2025 is the largest year on record at $30,406, 7.7 times the $3,929 reported in 2021. Among psychiatric/mental health clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 718 payments — averaging $91.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Axsome Therapeutics, Inc.$38K
- AbbVie$17K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$5K
- Johnson & Johnson$1K
- Otsuka America Pharmaceutical, Inc.$956
- Takeda Pharmaceuticals U.S.A., Inc.$593
- plus $3K from 16 others
What the payments were for
- Consulting fees$17,54027%
- Speaking & faculty fees$29,35045%
- Travel & lodging$6,31710%
- Food & beverage$12,30119%
- Education$60%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Axsome Therapeutics, Inc. | 77 | $37,502 |
| AbbVie | 232 | $17,229 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 105 | $5,227 |
| Johnson & Johnson | 67 | $1,249 |
| Otsuka America Pharmaceutical, Inc. | 54 | $956 |
| Takeda Pharmaceuticals U.S.A., Inc. | 51 | $593 |
| Neurocrine Biosciences, Inc. | 16 | $427 |
| Sunovion Pharmaceuticals Inc. | 21 | $373 |
| Alkermes, Inc. | 14 | $368 |
| Vanda Pharmaceuticals Inc. | 15 | $311 |
| Almatica Pharma LLC | 16 | $308 |
| Lundbeck LLC | 14 | $272 |
| E.r. Squibb & Sons, L.L.C. | 12 | $260 |
| Bausch Health US, LLC | 8 | $152 |
| Corium, LLC | 6 | $90 |
| Teva Pharmaceuticals USA, Inc. | 2 | $40 |
| Noven Therapeutics, LLC | 2 | $38 |
| Indivior Inc. | 2 | $36 |
| Braeburn Inc. | 1 | $26 |
| Tris Pharma Inc | 1 | $24 |
| Neos Therapeutics, LP | 1 | $17 |
| Jazz Pharmaceuticals Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$65,514 in reported general payments places this provider in the 95th percentile of 3,096 psychiatric/mental health providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 289 | $439,160 |
| SpravatoEsketamine Hcl | 66 | $231,051 |
| AuvelityDextromethorphan Hbr/Bupropion | 155 | $181,426 |
| RexultiBrexpiprazole | 21 | $52,750 |
| CaplytaLumateperone Tosylate | 19 | $36,311 |
| Vilazodone Hcl | 249 | $19,330 |
| ZubsolvBuprenorphine Hcl/Naloxone Hcl | 12 | $9,734 |
| Aripiprazole | 217 | $7,843 |
| Duloxetine Hcl | 348 | $4,862 |
| Doxepin Hcl | 88 | $4,525 |
| InvegaPaliperidone | 11 | $3,807 |
| Lurasidone Hcl | 12 | $3,499 |
| Bupropion Hcl SrBupropion Hcl | 253 | $3,451 |
| Olanzapine | 191 | $3,263 |
| Quetiapine Fumarate | 215 | $2,888 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar | $17,229 | $439,160289 claims |
| Johnson & JohnsonSpravato, Invega | $1,249 | $234,85877 claims |
| Axsome Therapeutics, Inc.Auvelity | $37,502 | $181,426155 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $956 | $52,75021 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $5,227 | $36,31119 claims |
| Almatica Pharma LLCSertraline Hcl | $308 | $660137 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,096 psychiatric/mental health providers in Florida.
Other psychiatric/mental health in New Smyrna Beach
- Roger RiveraKissimmee$1.6M
- Bethanie Simmons BecilJacksonville$782K
- Hannah PhillipsMaitland$455K
- Scott DurrancePensacola$224K
- Eudaldo AponteHialeah$214K
- Heather WarrenTallahassee$172K
- Angela DavenportAlachua$83K
- Natalie MoodyWinter Haven$75K
- Carolann BrooksCelebration$57K
- Linda SkalskyGainesville$53K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.